Ana Kerguelen Fuentes

TL;DR: The MPN-SAF TSS is a concise, valid, and accurate assessment of MPN symptom burden with demonstrated clinical utility in the largest prospective MPN symptoms study to date.

TL;DR: Cluster analysis from prospectively gathered symptom burden data in 1470 international patients with essential thrombocythemia, polycythemia vera, or myelofibrosis assessed for the presence of clusters and relationship to disease features and prognosis.

TL;DR: It is suggested that patients with PV who have any one of the features in question (known HU use, known phlebotomy, or splenomegaly) have significant PV-associated symptoms and it demonstrates that many PV symptoms remain severe independent of the number of features present.

TL;DR: The role gender plays in the symptomatology of myeloproliferative neoplasms remains under-investigated in this paper, where the authors evaluated how gender relates to patients' characteristics, disease complications and overall symptom expression.

TL;DR: It is suggested that MF patients with thrombocytopenia experience greater symptomatic burden than MF patients without thromBocy topenia and may benefit from additional therapies.